Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Nuclear Envelope Dynamics in Interstrand Crosslink Repair: Mechanisms and Targets
EF 2025-26
Résumé
Fanconi Anemia is a rare inherited disorder in which a person's cells cannot properly repair a dangerous type of DNA damage called interstrand crosslinks. Because of this, patients suffer from bone marrow failure and have an increased risk of developing cancer. Currently, treatment options are limited, and progress toward new therapies has been slow.
Recent work from the Mekhail Lab (University of Toronto) has found that when DNA is damaged, the nucleus—the part of the cell that holds our DNA—can reshape itself to form tube-like structures that help deliver repair proteins directly to the damage sites. This process, called nucleomorphosis, uses some of the same proteins needed to repair the type of DNA damage found in patients with Fanconi Anemia, suggesting a possible connection.
My research will explore whether boosting nucleomorphosis can help cells affected by Fanconi Anemia repair their DNA more effectively. To do this, I will perform experiments in patient-derived cells and use advanced imaging techniques to measure DNA damage and observe changes in nuclear structure. I will also test whether certain drugs can enhance nucleomorphosis and improve DNA repair in these cells.
If successful, this work could reveal an entirely new treatment approach for people suffering from Fanconi Anemia. Enhancing nucleomorphosis may help protect early-stage patients by strengthening DNA repair in their cells, while blocking it may slow the growth of cancer cells that often arise in advanced cases of the disease. This project is part of an international effort aimed at developing meaningful new therapies for individuals and families affected by this devastating condition.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572753
Name
Freimanis Joshua L
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Prcname2
Special Cases - Awards Programs
Projecttitle
Nuclear Envelope Dynamics in Interstrand Crosslink Repair: Mechanisms and Targets
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer Cell Biology; Dna Damage Response; Dna Replication Stress; Fanconi Anemia; Functional Genomics; Genome Instability; Interstrand Crosslink Repair; Microtubule Biology; Nuclear Envelope Dynamics; Therapeutic Target Discovery
Abstract
Fanconi Anemia is a rare inherited disorder in which a person's cells cannot properly repair a dangerous type of DNA damage called interstrand crosslinks. Because of this, patients suffer from bone marrow failure and have an increased risk of developing cancer. Currently, treatment options are limited, and progress toward new therapies has been slow.
Recent work from the Mekhail Lab (University of Toronto) has found that when DNA is damaged, the nucleus—the part of the cell that holds our DNA—can reshape itself to form tube-like structures that help deliver repair proteins directly to the damage sites. This process, called nucleomorphosis, uses some of the same proteins needed to repair the type of DNA damage found in patients with Fanconi Anemia, suggesting a possible connection.
My research will explore whether boosting nucleomorphosis can help cells affected by Fanconi Anemia repair their DNA more effectively. To do this, I will perform experiments in patient-derived cells and use advanced imaging techniques to measure DNA damage and observe changes in nuclear structure. I will also test whether certain drugs can enhance nucleomorphosis and improve DNA repair in these cells.
If successful, this work could reveal an entirely new treatment approach for people suffering from Fanconi Anemia. Enhancing nucleomorphosis may help protect early-stage patients by strengthening DNA repair in their cells, while blocking it may slow the growth of cancer cells that often arise in advanced cases of the disease. This project is part of an international effort aimed at developing meaningful new therapies for individuals and families affected by this devastating condition.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Freimanis, Joshua L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~